辅酶Q10通过调节HDAC4 O-GlcNAcylation来缓解心肌梗塞
Wei Xie1, Xiang Gao1, Shifei Song1
1Department of Cardiovascular Medicine, Xinjiang Production & Construction Corps Hospital, Urumqi, Xinjiang, China.
BioFactors (Oxford, England)
|March 5, 2026
概括
辅酶Q10 (CoQ10) 通过减少细胞死亡,纤维化和炎症来保护心肌梗塞 (MI) 后的心脏. 它通过调节O-GlcNAcylation和降低HDAC4表达来实现这一目标,为MI提供了潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物化学 生物化学
背景情况:
- 心肌梗塞 (MI) 是全球主要的死亡原因.
- 了解MI背后的分子机制和识别心脏保护剂对于改善患者的治疗结果至关重要.
- 共酶Q10 (CoQ10) 是一种重要的抗氧化剂,在心血管疾病中具有潜在的治疗作用.
研究的目的:
- 为了研究辅酶Q10 (CoQ10) 的心脏保护作用,在心肌缺血-再输液 (MI) 的老鼠模型中.
- 阐明CoQ10发挥其保护作用的分子机制,重点关注O-GlcNAcylation和HDAC4.4.
- 评估CoQ10对心肌细胞亡,纤维细胞激活和心脏纤维化的影响.
主要方法:
- 建立了一种老鼠心肌缺血-再输血 (MI) 模型.
- 评估了心脏病发作的大小,组织学变化,细胞亡 (TUNEL,流细胞计) 和纤维化 (马森,西里乌斯红色染色).
- 利用西方斑点,免疫光,ELISA和基于细胞的测试来分析分子点,包括O-GlcNAcylation,OGT,OGA和HDAC4,以及炎症标志物和纤维细胞活性.
主要成果:
- CoQ10治疗显著减少了心脏病发作的大小,心肌细胞亡,心脏纤维化和MI老鼠的炎症.
- CoQ10通过降低OGT和增加OGA表达来调节O-GlcNAcylation,从而降低HDAC4水平.
- CoQ10抑制了纤维细胞的增殖和迁移,并减少了原沉积,显示出抗纤维细胞的特性.
结论:
- 辅酶Q10 (CoQ10) 在大鼠模型中显示出显著的心脏保护作用,防止心肌缺血-再输血损伤.
- 辅酶Q10通过调节O-GlcNAc的修饰和减少HDAC4的表达和稳定性来发挥其保护作用.
- 这些发现凸显了CoQ10作为心肌梗塞的潜在治疗剂,准了与心脏损伤和重塑有关的关键分子通路.
更多相关视频
07:14A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
15.4K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
4.6K
相关概念视频
01:17Ischemic Heart Disease: Overview
3.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
01:26Coronary Artery Disease II: Pathophysiology
847
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847
01:43Electron Transport Chain: Complex III and IV
9.5K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.5K
01:26Coronary Artery Disease IV: Preventive Measures
786
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
588
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
01:30Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K